Council for Tobacco Research
Annual Report of the Scientific Director [St]
Abstract
MAR
Fields
- Depository Date
- 25 Sep 1995
- Master ID
- Ctrmn00000667-6967
Related Documents:- CTRMN000667-0808 Deposition of Robert F. Gertenbach [Deposition of Gertenbach in the Matter of Rogers]
- CTRMN000809-0827 Certificate of Incorporation of the Council for Tobacco Research - U.S.A., Inc. Under Section 402 of the Not-for-Profit Corporation Law [Details Definitions and Purposes for Forming A Not-for-Profit Corporation]
- CTRMN000828-0848 by-Laws of the Council for Tobacco Research - U.S.A., Inc. [Rules and Regulations for the Operation of the Council]
- CTRMN000849-0854 Application for Research Grant [A Blank Funding Request Form for Scientific Studies]
- CTRMN000855-0856 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Stipulations for Receiving A Funding Award]
- CTRMN000857-0859 [Suggestions and Guidelines for Submitting A Request for A Grant]
- CTRMN000860-0871 [Transmittal of Information for Securing A Research Grant]
- CTRMN000872-0882 [A Blank Funding Request Form for Scientific Studies]
- CTRMN000883-0892 Closing Dates for Application of Renewal Grants Requirements: (1) Progress Report and (2) Abstract of Progress Report [Procedural Information for Applying for Continued Funding for Scientific Project]
- CTRMN000893-1031 Published Reports on Research Supported in Whole or in Part by the Council for Tobacco Research - U.S.A. Formerly the Tobacco Industry Research Committee [List of Scientific Studies]
- CTRMN001032-1045 1956 Report of the Scientific Director [St]
- CTRMN001046-1094 1957 Report of the Scientific Director [St]
- CTRMN001095-1127 1958 Report of the Scientific Director [St]
- CTRMN001128-1163 1959 Report of the Scientific Director [St]
- CTRMN001164-1201 1960 Report of the Scientific Director [St]
- CTRMN001202-1239 1961 Report of the Scientific Director [St]
- CTRMN001240-1269 1962 Report of the Scientific Director [St]
- CTRMN001307-1346 Report of the Scientific Director [St]
- CTRMN001347-1387 Report of the Scientific Director [St]
- CTRMN001388-1429 Report of the Scientific Director [St]
- CTRMN001430-1485 Annual Report of the Scientific Director [St]
- CTRMN001486-1529 Report of the Scientific Director [St]
- CTRMN001530-1578 Annual Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001579-1632 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001633-1681 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001682-1727 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001728-1771 1975 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001772-1816 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001817-1860 1977 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001861-1913 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001914-1967 1979 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001968-2025 1980 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002026-2088 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002089-2148 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002149-2223 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002224-2942 Application for Research Grant An Investigation of the Spectral and Chromatographic Characteristics of Aromatic Hydrocarbons. [Study on High Temperature Gas-Liquid Partition Chromatography]
- CTRMN002943-3303 [Regarding Polio and Tuberculosis As Predisposing Factor in Lung Cancer]
- CTRMN003304-3322 Tobacco-Health Research Program [Display Case Showing Main Areas of Investigation]
- CTRMN003323-3326 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Rules for Approval of Grants Relating to Tobacco Use and Human Health]
- CTRMN003327-3337 A Brief Review of the Smoking-Lung Cancer Theory [Concerning Problems of Cigarette Lung Cancer Causation and Why They Have No Been Solved]
- CTRMN003338-3357 A Scientific Perspective on the Cigarette Controversy [Views of Cancer Experts on Causes of Lung Cancer]
- CTRMN003358-3365 Some Information About... The Council for Tobacco Research-U.S.A., Inc. ...and Its Research Program [Informs About the Purpose and Function of Organization's Research Program]
- CTRMN003366-3374 the Research Program of the Scientific Advisory Board to the Council for Tobacco Research - U.S.A. [Informs the Purposes, Policies, and the Research Program of the Board]
- CTRMN003375-3419 the Cancer-Smoking Controversy [Regards the Fallacious Conclusions of Cigarette Smoking Causing Lung Cancer From A Mathematical and Scientific Point of View]
- CTRMN003420-3425 Some Harvard Men & the Smoking Habit [Give Results of Questionnaire Relating to Biological Factors of Tobacco Smoking]
- CTRMN003426-3431 the Pathologic Anatomy of the Bronchial Tree and Lungs Reprinted From the Archives of Pathology Vol. 70 [St Finds of Equivocal Results with the Use of Tobacco]
- CTRMN003432-3437 Some Statistical Observations on A Co-Operative Study of Human Pulmonary Pathology Reprinted From the Proceedings of the National Academy of Sciences Vol. 43 No. 12 [St Examines Systematically the Conditions at Autopsy in the Bronchial Mucosae of Random Cases]
- CTRMN003438-3442 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology, II [Results Show Pathological Lungs in Different Cities Are Acutally Different]
- CTRMN003443-3447 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology. II [Study Comparing Pathological Conditions in 8 Different Cities Shows That Conditions Are All Different]
- CTRMN003448-3456 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology [Systematic Examinations of the Conditions at Autopsy in the Bronchial Mucosae of Run-of-the-Mill Cases]
- CTRMN003457-3464 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology III [When Probability Is Doubtful the Use of Variable Tables to Calculate Results Is the Best Way to Make A Precise and Accurate Answer for Sufficient Range of Pathological Conditions]
- CTRMN003465-3476 Differences Between Smokers and Nonsmokers [Differences Between Smokers and Nonsmokers Have to Do with Personality Traits and Physiologic Criteria]
- CTRMN003477-3485 the Psychology of Smoking [Smoking Is Determined by Certain Personality Variables and Personal Needs]
- CTRMN003486-3490 the Tobacco and Health Research Program of the Scientific Advisory Board [Regarding Information the Tobacco Industry Research Committee Do for the Research Program]
- CTRMN003491-3558 Tobacco Consumption in Various Countries [Results of Cigarette and Cigar Smokers From Different Countries]
- CTRMN003559-3560 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Guidelines for Which Grants Are Approved]
- CTRMN003561-3780 Tobacco Smoking in the United States in Relation to Income Marketing Research Report No. 189 [A Report Compiled by the Bureau of the Census for the United States Public Health Service on Smoking Characteristics in Relation to Income, Age, Region, Urban-Rural Residence and Occupation.]
- CTRMN003781-3781 Operating Results 1982 and Budget 1983 [Record of Expenditures]
- CTRMN003782-3782 Operating Results for Ten-Months Ended 10/31 Budget 11/1/83 Through 10/31/84 [Record of Expenditures]
- CTRMN003783-3783 Actual Operating Fiscal Year 1984 and Budget Fiscal Year 1985 [Record of Expenditures]
- CTRMN003784-3787 Confidential Report on Meeting January 18, 1954 Tobacco Industry Research Committee (TIRC) [St]
- CTRMN003788-3797 Confidential Report on Meeting March 15, 1954 Tobacco Industry Research Committee [St]
- CTRMN003798-3800 Tobacco Industry Research Committee Meeting [St]
- CTRMN003801-3815 Tobacco Industry Research Committee Meeting [St]
- CTRMN003816-3835 Tobacco Industry Research Committee Meeting [St]
- CTRMN003836-3852 Tobacco Industry Research Committee Meeting November 3, 1955 [St]
- CTRMN003853-3869 Tobacco Industry Research Committee Meeting February 14, 1956 [St]
- CTRMN003870-3895 Tobacco Industry Research Committee Meeting October 9, 1956 [St]
- CTRMN003896-3907 Tobacco Industry Research Committee Meeting May 9, 1957 [St]
- CTRMN003908-3923 Tobacco Industry Research Committee Meeting November 8, 1957 [St]
- CTRMN003924-3931 Tobacco Industry Research Committee Meeting May 8 1958 [St]
- CTRMN003932-3939 Tobacco Industry Research Committee Meeting November 6, 1958 [St]
- CTRMN003940-3945 Tobacco Industry Research Committee Meeting [St]
- CTRMN003946-3956 Tobacco Industry Research Committee Meeting December 10, 1959 [St]
- CTRMN003957-3969 Tobacco Industry Research Committee Meeting November 15, 1960 [St]
- CTRMN003970-3982 Tobacco Industry Research Committee Meeting October 18, 1961 [St]
- CTRMN003983-3991 Tobacco Industry Research Committee Meeting [St]
- CTRMN003992-4002 Tobacco Industry Research Committee Meeting November 15, 1962 [St]
- CTRMN004003-4006 the Council for Tobacco Research - U.S.A. March 5, 1964 [St]
- CTRMN004007-4014 the Council for Tobacco Research - U.S.A. June 8, 1965 [St]
- CTRMN004015-4020 the Council for Tobacco Research - U.S.A. January 27, 1967 [St]
- CTRMN004021-4026 the Council for Tobacco Research - U.S.A. January 24, 1968 [St]
- CTRMN004027-4034 the Council for Tobacco Research - U.S.A. January 31, 1969 [St]
- CTRMN004035-4041 Minutes of the First Meeting of the Board of Directors [St]
- CTRMN004042-4048 Minutes of the Second Meeting of the Board of Directors January 29, 1971 [St]
- CTRMN004049-4052 Minutes of the Meeting of the Executive Committee of the Board of Directors June 24, 1971 [St]
- CTRMN004053-4057 Minutes of of the Board of Directors January 28, 1972 [St]
- CTRMN004058-4061 Minutes of the Meeting of the Board of Directors November 10, 1972 [St]
- CTRMN004062-4066 Minutes of the Meeting of the Board of Directors January 26, 1973 [St]
- CTRMN004067-4070 Minutes of the Special Meeting of the Board of Directors July 26, 1973 [St]
- CTRMN004071-4076 Minutes of the Meeting of the Board of Directors February 1, 1974 [St]
- CTRMN004077-4081 Minutes of the Special Meeting of the Board of Directors June 13, 1974 [St]
- CTRMN004082-4086 Minutes of the Special Meeting of the Board of Directors December 5, 1974 [St]
- CTRMN004087-4091 Minutes of the Meeting of the Board of Directors January 31, 1975 [St]
- CTRMN004092-4095 Minutes of the Special Meeting of the Board of Directors July 24, 1975 [St]
- CTRMN004096-4141 Retirement Plan for Employees of the Council for Tobacco Research - U.S.A., Inc. Amended and Restated As of July 1, 1975 [St]
- CTRMN004142-4147 Minutes of the Special Meeting of the Board of Directors December 10, 1975 [St]
- CTRMN004148-4153 Minutes of the Meeting of the Board of Directors January 30, 1976 [St]
- CTRMN004154-4157 Minutes of the Special Meeting of the Board of Directors September 9, 1976 [St]
- CTRMN004158-4161 Minutes of the Meeting of the Board of Directors January 28 1977 [St]
- CTRMN004162-4166 Minutes of the Special Meeting of the Board of Directors April 21 1978 [St]
- CTRMN004167-4167 Minutes of the Special Meeting of the Executive Committee of the Board of Directors August 17, 1978 [St]
- CTRMN004168-4172 Minutes of the Meeting of the Board of Directors January 29, 1979 [St]
- CTRMN004173-4176 Minutes of the Meeting of the Board of Directors February 1, 1980 [St]
- CTRMN004177-4178 Minutes of the Board of Directors Executive Committee Meeting New York, New York [St]
- CTRMN004179-4184 Minutes of the Meeting of the Directors January 30, 1981 [St]
- CTRMN004185-4189 Minutes of the Special Meeting of the Board of Directors June 25, 1981 [St]
- CTRMN004190-4192 Minutes of A Meeting of Certain Members of the Board of Directors [St]
- CTRMN004193-4198 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004199-4205 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004206-4209 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004210-4213 Minutes of the Special Meeting of the Board of Directors [St]
- CTRMN004214-4217 Confidential Report of Scientific Advisory Board Meeting [St]
- CTRMN004218-4221 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004222-4226 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004227-4232 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004233-4236 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004237-4240 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004241-4246 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004247-4251 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004252-4256 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004257-4266 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004267-4283 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004284-4287 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004288-4292 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004293-4297 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004298-4303 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004304-4310 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004311-4316 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004317-4319 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004320-4323 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004324-4330 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004331-4335 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004336-4339 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004340-4344 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004345-4348 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004349-4353 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004354-4357 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004358-4366 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004367-4370 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004371-4376 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004377-4390 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004391-4395 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004396-4400 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004401-4404 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004405-4409 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004410-4413 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004414-4416 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004417-4420 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004421-4426 Confidential Report Scientific Board Meeting [St]
- CTRMN004427-4430 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004431-4433 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004434-4436 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004437-4439 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004440-4443 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004444-4446 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004447-4450 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004451-4454 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004455-4459 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004460-4463 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004464-4467 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004468-4472 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004473-4475 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004476-4480 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004481-4484 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004485-4492 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004493-4497 Confidential Report Scientific Advisory Board Meeting September 23-24, 1967 [St]
- CTRMN004498-4501 Confidential Report Scientific Advisory Board Meeting December 9-10, 1967 [St]
- CTRMN004502-4505 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004506-4510 Confidential Report Scientific Advisory Board Meeting La Jolla, California March 2-3-4, 1968 [St]
- CTRMN004511-4516 Confidential Report Scientific Advisory Board Meeting New York New York May 25-26, 1968 [St]
- CTRMN004517-4522 Confidential Report Scientific Advisory Board Meeting New York, New York September 14-15, 1968 [St]
- CTRMN004523-4526 Confidential Report Scientific Advisory Board Meeting New York, New York December 8-9, 1968 [St]
- CTRMN004527-4531 Confidential Report Scientific Advisory Board Meeting New York, New York March 22-23, 1969 [St]
- CTRMN004532-4538 Confidential Report Scientific Advisory Board Meeting New York, New York May 16-18, 1969 [St]
- CTRMN004539-4544 Confidential Report Scientific Advisory Board Meeting New York, New York September 12-14, 1969 [St]
- CTRMN004545-4549 Confidential Report Scientific Advisory Board Meeting New York, New York December 12-14, 1969 [St]
- CTRMN004550-4555 Confidential Report Scientific Advisory Board Meeting Colorado Springs, Colorado March 20-22, 1970 [St]
- CTRMN004556-4560 Confidential Report Scientific Advisory Board Meeting New York, New York [St]
- CTRMN004561-4569 Confidential Report Scientific Advisory Board Meeting New York, N.Y. September 18-19-20, 1970 [St]
- CTRMN004570-4578 Confidential Report Scientific Advisory Board Meeting Chicago, Illinois January 15,16, 1971 [St]
- CTRMN004579-4585 Confidential Report Scientific Advisory Board Meeting New York, N.Y. May 7-8-9, 1971 [St]
- CTRMN004586-4593 Confidential Report Scientific Advisory Board Meeting New York, N.Y. September 24-25-26, 1971 [St]
- CTRMN004594-4598 Confidential Report Scientific Advisory Board Meeting New York, N.Y. [St]
- CTRMN004599-4604 Confidential Report Scientific Advisory Board Meeting Palm Springs, California March 24-25-26, 1972 [St]
- CTRMN004605-4609 Confidential Report Scientific Advisory Board Meeting New York, New York June 9-11, 1972 [St]
- CTRMN004610-4614 Confidential Report Scientific Advisory Board Meeting New York, New York September 15-17, 1972 [St]
- CTRMN004615-4623 Confidential Report Scientific Advisory Board Meeting New York, New York March 14-15-16, 1973 [St]
- CTRMN004624-4626 Meeting Executive Committee of the Scientific Advisory Board June 13, 1973 New York, N.Y. [St]
- CTRMN004627-4634 Confidential Report Scientific Advisory Board Meeting New York, New York October 10-11-12, 1973 [St]
- CTRMN004635-4643 Meeting Executive Committee of the Scientific Advisory Board December 4, 1973 New York, N.Y. [St]
- CTRMN004644-4654 Confidential Report Scientific Advisory Board Meeting New York, New York October 30-31 November 1, 1974 [St]
- CTRMN004655-4656 Meeting Executive Committee of the Scientific Advisory Board December 13, 1974 New York, N.Y. [St]
- CTRMN004657-4664 Confidential Report Scientific Advisory Board Meeting Santa Barbara, California March 26-27-28, 1975 [St]
- CTRMN004665-4672 Confidential Report Scientific Advisory Board Meeting New York, New York September 10-11-12, 1975 [St]
- CTRMN004673-4675 Meeting Executive Committee of the Scientific Advisory Board New York, New York December 13, 1975 [St]
- CTRMN004676-4683 Confidential Report Scientific Advisory Board Meeting Santa Barbara, California March 17-18-19, 1976 [St]
- CTRMN004684-4686 Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 11, 1976 [St]
- CTRMN004687-4694 Confidential Report Scientific Advisory Board Meeting New York, New York September 28-29-30, 1976 October 1, 1976 [St]
- CTRMN004695-4697 Meeting of the Executive Committee of the Scientific Advisory Board Bethesda, Maryland December 1, 1976 [St]
- CTRMN004698-4706 Confidential Report Scientific Advisory Board Meeting Tuscon, Arizona March 23-25, 1977 [St]
- CTRMN004707-4708 Meeting of the Executive Committee of the Scientific Advisory Board Tuscon, Arizona March 25, 1977 [St]
- CTRMN004709-4710 Meeting of the Executive Committee of the Scientific Advisory Board New York, New York May 19, 1977 [St]
- CTRMN004711-4719 Confidential Report Scientific Advisory Board Meeting New York, New York October 26-28, 1977 [St]
- CTRMN004720-4723 Confidential Report Scientific Advisory Board Meeting Phoenix, Arizona January 16-17, 1978 [St]
- CTRMN004724-4724 Confidential Report Meeting of the Scientific Advisory Board Committee Phoenix, Arizona January 17, 1978 [St]
- CTRMN004725-4734 Confidential Report Scientific Advisory Board Meeting New York, New York April 26-27-28, 1978 [St]
- CTRMN004735-4735 Confidential Report Scientific Advisory Board Executive Committee New York, New York April 27, 1978 [St]
- CTRMN004736-4737 Confidential Report Meeting for the Scientific Advisory Board New York, New York July 27, 1978 [St]
- CTRMN004736A-4736A Confidential Report Meeting of the Scientific Advisory Board New York, New York July 27, 1978 [St]
- CTRMN004738-4747 Confidential Report Scientific Advisory Board Meeting New York, New York October 18-19-20, 1978 [St]
- CTRMN004748-4750 Confidential Report Meeting of the Scientific Advisory Board New York, New York December 20, 1978 [St]
- CTRMN004751-4759 Confidential Report Scientific Advisory Board Meeting New York, New York April 11-12-13, 1979 [St]
- CTRMN004760-4769 Confidential Report Scientific Advisory Board Meeting New York, New York October 17-18-19, 1979 [St]
- CTRMN004770-4770 Confidential Meeting of the Report Scientific Advisory Board New York, New York October 18, 1979 [St]
- CTRMN004771-4780 Confidential Report Scientific Advisory Meeting New York, New York Aprill 9-10-11, 1980 [St]
- CTRMN004781-4781 Confidential Report Executive Committee of the Scientific Advisory Board Meeting New York, New York June 20, 1980 [St]
- CTRMN004782-4783 Confidential Report Executive Committee of the Scientific Advisory Board Meeting New York, New York September 16, 1980 [St]
- CTRMN004784-4792 Confidential Report Scientific Advisory Board Meeting New York, New York October 8-9-10, 1980 [St]
- CTRMN004793-4794 Confidential Report Meeting of the Scientific Advisory Board New York, New York October 9, 1980 [St]
- CTRMN004795-4804 Confidential Report Scientific Advisory Board Meeting New York, New York April 8-9-10, 1981 [St]
- CTRMN004805-4805 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 8, 1981 [St]
- CTRMN004806-4806 Confidential Report Meeting of the Scientific Advisory Board New York, New York September 10, 1981 [St]
- CTRMN004807-4816 Confidential Report Scientific Advisory Board Meeting New York, New York October 14-15-16, 1981 [St]
- CTRMN004817-4818 Confidential Report Meeting of the Executive Committee Scientific Advisory Board New York, New York October 15, 1981 [St]
- CTRMN004819-4820 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York December 9, 1981 [St]
- CTRMN004821-4831 Confidential Report Scientific Advisory Board Meeting New York, New York April 21, 22, 23, 1982 [St]
- CTRMN004832-4833 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 21, 1982 [St]
- CTRMN004834-4843 Confidential Report Scientific Advisory Board Meeting New York, New York October 6,7,8, 1982 [St]
- CTRMN004844-4844 Confidential Report Meeting of the Executive Meeting of the Scientific Advisory Board New York, New York October 8, 1982 [St]
- CTRMN004845-4845 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board Scottsdale, Arizona February 24, 1983 [St]
- CTRMN004846-4857 Confidential Report Scientific Advisory Board Meeting New York, New York April 20, 21, 22, 1983 [St]
- CTRMN004858-4858 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 22, 1983 [St]
- CTRMN004859-4859 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 6, 1983 [St]
- CTRMN004860-4871 Confidential Report Scientific Advisory Board Meeting New York, New York October 12, 13, 14, 1983 [St]
- CTRMN004872-4882 Confidential Report Scientific Advisory Board Meeting New York, New York March 28, 29, 30, 1984 [St]
- CTRMN004883-4883 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York March 29, 1984 [St]
- CTRMN004884-4895 Confidential Report Scientific Advisory Board Meeting September 19, 20, 21, 1984 New York, New York [St]
- CTRMN004896-4896 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York September 20, 1984 [St]
- CTRMN004897-4897 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board Palm Beach, Florida February 25, 1985 [St]
- CTRMN004898-4898 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 16, 1985 [St]
- CTRMN004899-4910 Confidential Report Scientific Advisory Board Meeting April 15, 16, 17, 1985 New York, New York [St]
- CTRMN004911-4911 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 16, 1985 [St]
- CTRMN004912-4923 Confidential Report Scientific Advisory Board Meeting April 15, 16, 17, 1985 New York, New York [St]
- CTRMN004924-4927 for Release: A.M.'s Wednesday, April 14, 1954 ["Reaction to the Compendium "A Scientific Perspective on the Cigarette Controversy""]
- CTRMN004928-4929 for Release: A.M.'s Tuesday, April 27, 1954 [Scientific Advisory Board Organized Early to Begin Research Into All Phases of Tobacco Use and Health for the Year]
- CTRMN004930-4931 for Release in A.M.'s of Tuesday, May 18, 1954 [Proposals Submitted for Cancer Research Projects for Consideration by Scientific Advisory Board]
- CTRMN004932-4933 for Release After 10:30 A.M., June 15, 1954 [Appointment of Dr. Clarence Cook Little Announced by the Tobacco Research Industry Committee]
- CTRMN004934-4937 for Immediate Release [American Cancer Society Survey Conveys the Need to Further Research to Discover Cause of Cancer and Cardiovascular Disease]
- CTRMN004938-4939 for Release in Am's of Tuesday, July 20, 1954 [Edwin B. Wilson of Harvard University Became A Member of Scientific Advisory Board of the Tobacco Industry Research Committee]
- CTRMN004940-4942 for Release: A.M.'s of Wednesday, July 28, 1954 Little Announces Research Policy of Tobacco Industry Research Committee [Three Main Areas to Be Covered by Research Program Announced]
- CTRMN004943-4944 for Release in A.M.'s Thursday, August 19, 1954 [Dr. Julius H. Comroe of University of Pennsylvania, Accepted Membership on Scientific Advisory Board of the Tobacco Industry Research Committee]
- CTRMN004945-4945 for Immediate Release (Monday, October 11, 1954) Dr. Little Gives TIRC View [Little States That No Convincing Evidence Has Yet Been Found to Prove That Cigarette Smoking Causes Lung Cancer]
- CTRMN004946-4946 for Immediate Release (Tuesday, October 12, 1954) [Timothy V. Hartnet, Chairman of Board, Stated That Public Should Be Reminded That No Lung Cancer Causing Agent Has Yet Been Identified in Tobacco]
- CTRMN004947-4947 for Release: Wednesday, October 20, 1954 Hartnett Approves Care in Research [Committee to Be Sure That Reliable Evidence Is Available Before Announcing Important Conclusions to the Public About Smoking]
- CTRMN004948-4948 for Immediate Release (Thursday, October 21, 1954) Hartnett Comments on Cigarette Paper Burning [Timothy V. Hartnett Comments That A Cancer Causing Compound on Skin of Mice Has Been Produced by Burning Cigarette Paper Under Certain Lab Conditions]
- CTRMN004949-4952 for Release: A.M.'s, Monday, November 8, 1954 Tobacco Industry Research Committee Announces Initial Grants [Six Scientific Research Grants Totalling Over $82,000 Made Public]
- CTRMN004953-4954 for Release in A.M.'s, Monday, December 6, 1954 Scientific Associate Named by Tobacco Research Group [Robert C. Hockett Appointed As Scientific Director of TIRC to Help Develop Research Into Tobacco Use and Health]
- CTRMN004955-4956 for Immediate Release Cross-Country Lung Study Planned by Tobacco Group [Group of Pathologists Plan A Cooperative Study to Increase Knowledge of Lung Ailments]
- CTRMN004957-4959 for Release in Year-End Editions But Not Before December 27, 1954 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [TIRC Will Approve A Quarter of A Million Dollars for Research Into Public Health Problems by the End of 1954]
- CTRMN004960-4963 for Release: Monday A.M.'s, January 17, 1955 Tobacco Industry's New Research Grants Send Total to More Than $300,000 [New Research Grants Announced by TIRC to Relate to Both Human and Animal Scientific Studies]
- CTRMN004964-4966 for Release in A.M.'s of Friday, April 8, 1955 Tobacco Industry Group Votes Medical Research Fellowships [TIRC Announced Fellowship Program to Create Interest in Research Among Medical School Students]
- CTRMN004967-4969 Release Tuesday, May 17, 1955 and Thereafter Tobacco and Health Studies Cover Wide Range of Research [Although No Scientific Proof That Cigarettes or Air Pollution Cause Lung Cancer, Progress Is Being Made to Learn More About Tobacco Use and Health by the TIRC]
- CTRMN004970-4972 Tobacco Research Grants Increased to 490,000 Mark [Research Grants Are Created So Science Can Provide An Answer to Public Health Problems]
- CTRMN004973-4973 Hartnett Comments on Auerbach Paper [Many Studies on Human Lung Tissue, Not Enough Data Available to Draw A Conclusion Yet]
- CTRMN004974-4975 Anti-Smoking Theories Not Based on Complete Scientific Knowledge [Scientific Investigation Into What the Real Effects Are From Tobacco Use]
- CTRMN004976-4977 Hartnett Comments on Statistical Study [Research Intensified in Past Year, No Proof That Smoking Causes Cancer]
- CTRMN004978-4980 Doctor's Survey Termed 'biased, 'says Hartnett [Questionnaire Would Give No Concrete Conclusions About Tobacco Causing Cancer]
- CTRMN004981-4982 Hartnett Alerts Burley Men to Challenge Tobacco Attacks [Doctors Are Expressing Their Doubts About Statements Already Made; Tobacco Effects]
- CTRMN004983-4984 Bright Belt Warehouse Men Told Facts Challenge Critics [Still Looking for Proof That Tobacco Causes Cancer]
- CTRMN004985-4986 Tobacco Spokesman Says Facts and Position Are Unchanged [Various Experiments with Animals Showed That Cancer Was Not the Outcome From Tobacco Smoke]
- CTRMN004987-4987 Hartnett Comments on Statistical Study [Methods Used for Cancer Research Still Do Not Give Enough Information]
- CTRMN004988-4990 British Tobacco Experiments Unable to Induce Cancers [Still No Connection, Tests Will Continue]
- CTRMN004991-4993 Tobacco Research Grants Now Over 838,000 Mark [Tobacco Research Is Getting More Support From Doctors, Scientists, and Educators]
- CTRMN004994-4996 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Summary of the Past Years' Events in Tobacco Research]
- CTRMN004997-4999 Tobacco Research Fund Raised to 1,500,000 [Finding New Ways to Break Down Tobacco]
- CTRMN005000-5001 Tobacco Industry Group Renews Medical Research Fellowships [More Medical Students Are Receiving Fellowships Than Last Year]
- CTRMN005002-5003 Hartnett Statement on Cancer Meeting Reports [There Is Still Much Research to Be Done Before Tobacco Is Linked to Cancer]
- CTRMN005004-5005 [Pathologists From Around the Country Have Studied Human Lung Tissues Over the Past Year]
- CTRMN005006-5006 [Smoking Patterns Do Not Explain Differences in Lung Cancer]
- CTRMN005007-5008 Hartnett Cites British Tobacco Tests Failing to Produce Animal Cancer [the Search for Cancer Must Be Broadened and Intensified]
- CTRMN005009-5010 Hartnett Comments on Statistical Claims [Although Many Believe Smoking Causes Cancer, Scientists Still Have Not Found Any Prof]
- CTRMN005011-5011 [Present Knowledge Doesn't Hint A Relationship Between Smoking and Heart Problems]
- CTRMN005012-5016 Hartnett Comments on Cancer Society Booklet [Pamphlet Omits Some Important Research Results]
- CTRMN005017-5018 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Research Committee Needs More Scientific Investigation]
- CTRMN005019-5025 Tobacco Research Funds Reach 2.2 Million Mark [Over 60 Independent Scientists Throughout the Country Are Working in Institutions to Further the Research of Cancer and Tobacco Use, They Are Listed]
- CTRMN005026-5027 Hartnett Comments on French Report [French Are Reporting Rapid Cancer Formation in Mice, Hartnett Feels It Can't Be Judged on the Basis of New Reports Without Longer Consideration and Careful Analysis]
- CTRMN005028-5030 Harnett Cites Points for Clarification in Tobacco Health Study [Smoking Study Reached the Public's Attention Before It Was Reviewed and Before the Facts Were Made Crystal Clear]
- CTRMN005031-5032 Hartnett Comments on Wynder News Stories [News Story Claims That Assumptions Have Been Made About Mouse Skin Painting Experiments]
- CTRMN005033-5037 Statement on Smoking and Health Studies [Scientists Are Developing A Program for Different Phases of Tobacco Use and Health, Members Listed]
- CTRMN005038-5045 Hartnett Says Statistics Do Not Establish Causes [Studies Are Open to Assumptions and Certain Selection of Subjects]
- CTRMN005046-5048 Hartnett Cites Scientists Doubting Smoking-Cancer Theory [the Surgeon General Believes the Studies Are Missing Essential Facts That Should Be Acknowledged]
- CTRMN005049-5050 Scientist Comments on Benzpyrene Report [Benzpyrane in Tobacco Smoke, Under Investigation for Years Caused Cancer in Lab Animals But Not Humans]
- CTRMN005051-5055 "Cancer Researcher Challenges "Cause and Effect" Charges Against Smoking" [It's Difficult to Have A Cause and Effect Relationship When Dealing with Cancer and Tobacco Use]
- CTRMN005056-5056 [Atlantic Monthly Gives A Misleading Picture of Dr. Little and His Public Position]
- CTRMN005057-5058 Tobacco Committee Chairman Comments on Cancer Society Talk [Many Unresolved Questions About Tobacco Causing Cancer Don't Stop Researching]
- CTRMN005059-5061 Tobacco Research Scientist Discusses Smoking Question [Most Tend to Believe the Anti-Cigarette Theory But It Shouldn't Be Confused with the Facts There's Still Not Enough Facts to Prove That Smoking Causes Cancer]
- CTRMN005062-5062 Hartnett Says Leaflet Admits Differing Opinions on Smoking [Leaflet Tells How Scientists Disagree on Evidence]
- CTRMN005063-5066 Research Program Throws Doubts on Smoking Charges [Incorrect Claims and Harmful Effects From Tobacco]
- CTRMN005067-5069 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [More and More Scientists Had Doubts and Disbeliefs in the Charges Against Smoking As A Cause of Cancer]
- CTRMN005070-5071 Tobacco Research Scientist Discusses Smoking Question [Scientists Say Smoking Has Been Proved Guilty When Linked with Human Health Problems]
- CTRMN005072-5072 Pamphlet Merely Review, Dr. Little Says [Opinions Is All the Author Gives in His Pamphlet Scientists Are Still Disputing]
- CTRMN005073-5076 TIRC Fund for Research Boosted to $2,700,000 [Grants for Independent Scientists Interested in Studying Problems of Cancer and Heart Disease When Related to Smoking]
- CTRMN005077-5080 [New Knowledge on Smoking and Health Questions]
- CTRMN005081-5081 [Veterans Study of Smoking Habits]
- CTRMN005082-5082 [Report on How There Was Existing Research Evidence and How It Was Ignored]
- CTRMN005083-5085 [Regarding Anti-Tobacco Movement]
- CTRMN005086-5086 [Benzpyrene in Cigarette Smoke]
- CTRMN005087-5088 [Experimental Evidence Is Weak]
- CTRMN005089-5089 Hartnett Says Article on Arsenic Goes Beyond Facts [Farmers Use of Insecticides with Arsenicals on Growing Tobacco Has Steadily Been Declining]
- CTRMN005090-5091 [Scientists Who Produce Conflicting Results Are Being Ignored by the Health Department]
- CTRMN005092-5094 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Even More Grants Have Been Made Available More Factors Have Been Associated with Lung Cancer]
- CTRMN005095-5100 Tobacco Industry Group Announces Research Grants [Grant Increases to $3,200,000 List of Grants Announced]
- CTRMN005101-5103 Tobacco-Health Research Described in 1958 Report [the Report Talked About Experiments That Were Unable to Produce Cancer and the Cause and Effect Theory]
- CTRMN005104-5104 [Report Shows That Other Factors Besides Smoking Have Been Causing Lung Cancer, But Scientists Do Not Dismiss the Fact That Lung Cancer Is Possibility From Smoking]
- CTRMN005105-5105 [Anti-Smoking Campaign Is Thought to Be A One-Sided Propaganda Effort]
- CTRMN005106-5106 [Questions Arise From on-Sided Study]
- CTRMN005107-5111 Cancer Scientist's Comments on Smoking-Lung Cancer Review [Evidence on Smoking and Lung Cancer Is Accumulating, Among Other Contributing Factors]
- CTRMN005112-5117 [Comments Relating to Observation on Various Studies]
- CTRMN005118-5122 Research Grants Announced by Tobacco Industry Group [$500,000 Was Added to Research Funds, A List of Recipients with the New Grants Is Mentioned]
- CTRMN005123-5127 Research Supported by Tobacco Committee Discussed in Scientific Director's Report [It Seems That Finding An Answer to Lung Cancer and Cardiovascular Diseases Are Too Complicated]
- CTRMN005128-5128 [Attacks on Tobacco, the Lung Cancer Issue Is Still Not Settled]
- CTRMN005129-5129 Nta Stand on Smoking Repeats Opinions [Statement Gives No Evidence and Is Dealing Mainly with Opinions]
- CTRMN005130-5132 Tobacco Research Group Adds New Scientific Associate [New Scientific Director Was Added to the TIRC, Curriculum of J. Morrison Brady]
- CTRMN005133-5134 Tobacco Research Group Cites Questions Raised in Heart Statement [Lack of Evidence Proposes New Questions and Doubts About Cardiovascular Disease]
- CTRMN005135-5137 New Evidence Shows Complexities of Lung Cancer, Scientist Says [Hundreds of Studies Indicate Many Factors Contribute to the Complex Chain That May Result in Lung Cancer, No One Can Figure Out the Right Factor and Still the Reported Lung Cancer Cases Are Rising]
- CTRMN005138-5140 New Grants to Scientists Made by Tobacco Research Group [Research Grants Totalling $523,000 Made to 40 Scientists This Year]
- CTRMN005141-5144 Cancer Research Opens Up New Areas, Extra Funds Appropriated for Study [TIRC Stepping Up Financial Support of Independent Health Research]
- CTRMN005145-5147 Scientists in 11 States Get Research Grants for Tobacco-Health Studies [17 Research Grants Totaling Nearly $200,00 Awarded to Scientists in 11 States for Studies of Tobacco Use and Health]
- CTRMN005148-5151 New Direction for Tobacco-Health Research in '61, Says Chairman of Tobacco Industry Research Committee [Future Research to Concentrate on How Lung Cancer and Heart Disease Originate]
- CTRMN005152-5160 Research on Smoking and Health Discussed by Scientific Advisory Board to T.I.R.C. [Health Research Expansion Called for in 22 Specific Areas]
- CTRMN005161-5162 Scientist Reports on Research Progress As T.I.R.C. Boosts Funds to $4,650,000 [Dr. Clarence Cook Little Proposed Steps for Medical Research]
- CTRMN005163-5163 Nation's Medical Students Offered Research Fellowships by Tobacco Research Group [Program Designed to Encourage Research As A Career]
- CTRMN005164-5168 Scientists in 14 States Get Research Grants for Tobacco-Health Studies [Fifteen Grants for New Research Announced]
- CTRMN005169-5173 Tobacco Industry Research Committee Adds $800,000 for New Research [Emphasis Put on Viruses, Bioassay, Psychological and Physiological Research]
- CTRMN005174-5176 ""Significant Developments" in Cancer Research Reviewed in Annual Report by Dr. C.C. Little" [Scientific Findings of the Past Year Reviewed]
- CTRMN005177-5179 Tobacco Research Group Offers Fellowships to Medical Students to Spur Interest in Research Work [Program Designed to Encourage Career in Research]
- CTRMN005180-5180 Tobacco Research Committee Chairman Comments on Mouse Skin Painting [Harmless Everyday Substances Can Cause Cancer in Laboratory Animals]
- CTRMN005181-5182 Smoking-Health Situation Calls for Facts, Not Emotions, Says Hartnett [Repetition Does Not Add to Scientific Knowledge]
- CTRMN005183-5217 Smoking-Health Situation Calls for Facts, Not Emotions, Says Hartnett [Repetition Does Not Add to Scientific Knowledge]
- CTRMN005218-5224 52 Additional Research Grants Made by Tobacco Industry Group [Money for Studies Designed to Give New Leads to Lung Cancer and Other Health Problems]
- CTRMN005225-5225 Medical Student Fellowships Offered by Tobacco Research Group [Program to Encourage Research]
- CTRMN005226-5228 Gaps Still Exist in Knowledge of Lung Cancer and Heart Disease, Says Little [Multiple Factors and Influences That Contribute to Lung Cancer Unknown]
- CTRMN005229-5230 Scientific Director of Tobacco Industry Research Committee Comment on Resolution by American Heart Association [TIRC Welcomes Recognition of Need for Further Research to Determine Full Facts About Smoking]
- CTRMN005231-5234 Tobacco Committee Adds $1 Million for Continuing Research Studies [Scientific Advisory Board Assured TIRC Will Provide More Funds]
- CTRMN005235-5235 [Scientific Director of TIRC Sent Telegrams to the Surgeon General and the President of the Ama]
- CTRMN005236-5236 [Ama Supports Research on Tobacco and Health]
- CTRMN005237-5239 [TIRC Renamed and Reorganized]
- CTRMN005240-5241 Dr. Howard B. Andervont Named to the Scientific Advisory Board [Editor of the Journal of the National Cancer Institute Appointed]
- CTRMN005242-5277 Tobacco Industry Group Awards $817,165 for Health Research [37 Additional Research Grants Have Been Awarded by the Ctr]
- CTRMN005278-5282 Scientific Director C.C. Little Reports Decade of Tobacco-Health Research [Findings on What Diseases Smoking Can Cause]
- CTRMN005283-5286 Council Awards $500,000 for Tobacco and Health Research [Number of Grants Awarded for Tobacco Use and Health Research]
- CTRMN005287-5291 Summary of the Testimony of Clarence C. Little Before the Senate Commerce Committee [Discussion on Cancer and How It Affects Our Bodies]
- CTRMN005292-5319 Council Awards $514,767 for Tobacco and Health Research [Number of Grants Awarded to Scientist Over the Period of 10 Years]
- CTRMN005320-5348 Tobacco - Health Studies Reviewed in Annual Report [Discussion on Cigarette Smoking Being Helpful with Causing Diseases in Smokers]
- CTRMN005349-5367 Tobacco and Health Research Awards Pass $9 Million Total [Grants Given to Scientist Studying Matter Related to Tobacco Use and Health]
- CTRMN005368-5375 Tobacco-Health Research Grants Awarded New York Scientists [Scientists Approved to Continue Research on Lung Cancer and Other Diseases]
- CTRMN005376-5382 Tobacco - Health Studies Reviewed in Annual Report [Studies of the Respiratory System in Experimental Animals and Human Patients Especially on Causes of Pulmonary Cancers]
- CTRMN005383-5384 [Opinions of Scientists That There Is No Relationship Between Smoking and Disease]
- CTRMN005385-5387 New Tobacco-Health Research Grants Total $2 Million [Number of Approved Grants for Studies on Tobacco Use and Health]
- CTRMN005388-5388 Furst Becomes Consultant to Tobacco Research Council [Dr. Furst Advise to Council on Programs Sponsored by Them]
- CTRMN005389-5393 Studies Raise Questions About Smoking As Health Hazard [Numerous Studies Done to Show What Effect Smoking Had on Our Health]
- CTRMN005394-5400 Broad Review of Tobacco-Health Picture Covered in Dr. Little's Latest Report Lung Cancer, Heart Disease, Chronic Pulmonary Ailments Are Complex in Nature, Says Noted Researcher Genetic and Environmental Factors May Be Involved Reports Scientific Director of Council for Tobacco Research [Recent Research Finding on Lung Cancer, Heart Disease and Chronic Pulmonary Ailments]
- CTRMN005401-5404 Significant Smoking-Health Finding Covered in Report by Dr. C.C. Little [Findings From Independent Scientists on Smoking and Health]
- CTRMN005405-5408 New Tobacco-Health Grants Announced; One Helps Revive Framinghan Heart Study [Awards Granted to Independent Scientists Researching Tobacco and Health]
- CTRMN005409-5412 New Scientific Findings About Cancer, Heart Disease, the Lung, Other Areas, Reported by Council for Tobacco Research [New Findings From Independent Scientists Relating to Tobacco and Health Issue]
- CTRMN005413-5415 New Smoking-Health Studies Boost Total to $23-Million [Council Awards More Grants to the Study of Lung Cancer, Viruses and Cancer, Heart Disease, and Chronic Pulmonary Ailments]
- CTRMN005416-5418 Progress in Tobacco-Health Research Achieved: Machines That Simulate Human Smoking [Machines to Help Scientists Effectively Study Smoke and Health Issues]
- CTRMN005419-5421 Noted Cancer Scientist Named Scientific Director of the Council for Tobacco Research [Dr. Hockett Who Was Acting Scientific Director Got Promoted to Research Director]
- CTRMN005422-5425 Massive Cancer Study Using Made-to-Order Mice [Study Using Mice to See If Human Lung Cancer Can Be Induced Regularly]
- CTRMN005426-5427 Tobacco Research Group Announces New Studies [12 New Studies Have Been Funded to Study Generic Factors in Lung Cancer and Emphysema and the Possible Influence of Nicotine on Fetal Growth]
- CTRMN005428-5429 Studies of Twins Expanded by Tobacco Research Group [Human Twins Used for Study to Determine Effects of Environment Agents on Various Diseases]
- CTRMN005430-5432 News About Smoking and Health Study Interaction of Genetic and External Influences in Lung Cancer [Studies Show That Only Minority of Smokers Get Lung Cancer Therefore Lung Cancer May Be Caused by Genetic Characteristics or External Influences Which People Have Been Exposed]
- CTRMN005433-5434 New Smoking and Health Grants Made by Tobacco Research Council [New Studies Have Received Grants to Continue Researching on Smoking and Health]
- CTRMN005435-5435 Yeaman Assumes Leadership of Council for Tobacco Research [Addison Yeaman Succeeds H.H. Ramm for Chairman and President of the Council for Tobacco Research]
- CTRMN005436-5438 14 New Studies Funded by Tobacco Research Council [Grants Awarded to Studies for Inhibition of Cancer by Different Chemicals, the Influence of Nicotine on Pregnancy and the Effects of Cigarette Smoke on the Body's Disease Fighting System]
- CTRMN005439-5441 Progress Being Made in Research on Emphysema [Scientist Discover Ways to Help Defend Against Emphysema]
- CTRMN005442-5444 14 New Smoking-Health Projects Are Approved [Recent Research Studies Dealing with Smoking and Health Have Been Given Grants]
- CTRMN005445-5446 Grants Awarded for New Smiking-Health Studies [Scientists Were Approved for Studying of Certain Enzymes in Human Lung Cancer and Emphysema]
- CTRMN005447-5448 Tobacco Research Report Discusses Heart Disease [Studies Have Found Progressive Atherosclerosis Rank First As Number One As Causes of Death From Cardiovascular Disease]
- CTRMN005449-5451 Grants Awarded for New Smoking-Health Research [New Studies Have Been Approved for Marker Substance That May Indicate Presence of Lung Cancer and on Smoking and Pregnancy]
- CTRMN005452-5453 Tobacco Research Group Funds New Smoking-Health Projects [A New Study for Relationship of Childhood Respiratory Disease to the Development of Adult Chronic Lung Disease]
- CTRMN005454-5455 Tobacco Research Group Reports... Funds for Smoking-Health Studies Pass $46,000,000 [Amount Council Has Given to Scientist for Research]
- CTRMN005456-5458 $5.9 Millions Given for Smoking-Healths Studies [Council Has Given Millions Over the Years to Researchers]
- CTRMN005459-5460 Tobacco Research Group Says... Continued Research Needed to Find Causes of Cancer and Other Major Diseases [Council Pledges to Continue to Give Financial Support to Scientists Studying Smoke-Health Issues]
- CTRMN005461-5462 $6 Million Granted for Smoking-Health Studies [Millions Given to Scientist for Further Study]
- CTRMN005463-5465 Tobacco Research Group Continues Funding for Independent Scientists [Council Has Provided Millions Over the Years to Researchers and Will Continue to Do So]
- CTRMN005466-5467 $5.5 Million Given for Smokin-Health Studies [Council Has Given Millions to New and on Going Studies Over the Years]
- CTRMN005468-5469 Annual Report Issued by Tobacco Research Group [Over 1.5882 Reports From Scientists Acknowledging Support From the Council Have Been Published]
- CTRMN005470-5473 $6 Million Awarded for 34 New Smoking-Health Studies [Millions Were Given to Scientists with New Studies and Continuing Ones From the Council]
- CTRMN005474-5474 Ctr's Latest Report Sets Abstract Record [More Reports Were Published From Scientists Acknowledgingg Support From Council for Tobacco Research Than Any Other Report Published in the Past]
- CTRMN005475-5475 Scientists Show... Growing Interest in Doing Smoking and Health Studies [Growing Number of Application Have Gone to the Council of Tobacco Research for Funding on Smoke Related Diseases]
- CTRMN005476-5479 $7 and A Half -Million Awarded for Smoking-Health Research [Millions Given to Scientists for Studying Lung Disease]
- CTRMN005480-5481 Council for Tobacco Research Announces... Hoyt and Hockett Retire After 30 Years: Gertenbach Is Named New President [Introduction to President of the Council for Tobacco Research]
- CTRMN005482-5482 Ctr's Annual Report Sets Abstract Record [the Number of Reports Acknowledging Support by the Council of Tobacco Research Is More Today Than It Was Years Ago]
- CTRMN005483-5485 Findings Published on Cigarette Smoke Inhalation Study with Mice [Results From Study Show That Smoke Did Not Produce Any Squamous Cell Lung Cancer]
- CTRMN005486-5525 Statement of Dr. Clarence Cook Little, Scientific Director, Tobacco Industry Research Committee, at Press Conference, University Club, New York City, June 15, 1954 [Regarding Relationship Between Lung Cancer and Tobacco]
- CTRMN005526-5533 "Transcript of Edward R. Murrow's First Tv Show on "Cigarettes and Lung Cancer"" [Regarding Experiments That Show That Cigarette Smoking Increases Chances for Lung Cancer]
- CTRMN005534-5541 "Transcript of Edward R. Murrow's Second Tv Show on "Cigarettes and Lung Cancer"" [Regarding Issue That Cigarette Smoke Does Not Cause Lung Cancer]
- CTRMN005542-5562 the Lung Cancer Problem and the Research Program of the Tobacco Industry Research Committee [Regarding Continuation of Study Dealing with Tobacco and Health]
- CTRMN005563-5573 A Report of Progress [Results From the Study of Smoking and Health Issue Will Greatly Depend on Well Planned and Well-Executed Scientific Research]
- CTRMN005574-5585 Tobacco and the Cardiovascular System the Program of the Tobacco Industry Research Committee [Program Strives to Discover Facts and Relationships Described with Objectivity]
- CTRMN005586-5597 A Search for Facts [Regarding Information Needed to Be Gathered on Smoking and Health Problems to Defend Industry]
- CTRMN005598-5605 the Lung Cancer Problem and the Research Program of the Tobacco Industry Research Committee [Discussion on Different Studies Will Continue to Be Made Until A Answer Is Found]
- CTRMN005606-5607 Cancer Research Guest Editorial Smoking and Lung Cancer Volume 16 [St Regarding Support Given to Scientist for Research]
- CTRMN005608A-5609 "Correspondence Regarding "Smoking and Health"" [Discussion on Researching on Tobacco and Health with Objectivity and Not Be Judgmental]
- CTRMN005608B-5609 Hypfibrinogenemia [Regarding Transfusions and Clotting Mechanism in A Case of Extraordinarily Delayed Post-Partum Hemorrhage]
- CTRMN005608C-5609 Diabetic Children [Admitting Omission of Different Data From Other Sources]
- CTRMN005608D-5609 Revocation of Licenses [Revoking of Registration From Dr. Louis A. Scinta]
- CTRMN005610A-5613 Mayo Clinic Head Believes Smoking Not Cancer Cause Tobacco and Health Volume 1 Number 1 [Smoking Not Believed to Be Cause of Lung Cancer, According to Some Noted Physicians]
- CTRMN005610B-5613 Six Experts State Doubts on Smoking-Cancer Theory Tell Congressmen Reasons for Position Tobacco and Health Volume 1 Number 1 [Reasons for Not Accepting Theory That Smoking Causes Lung Cancer]
- CTRMN005610C-5613 New Book Says Tobacco 'scare' Not Justified Tobacco and Health Volume 1 Number 1 [""Science Looks at Smoking"]
- CTRMN005610D-5613 Editors View Smoking-Cancer Tie As Unproved, Open Question Excerpts From Editorials Tobacco and Health Volume 1 Number 1 [Excessive Smoking Probably the Main Cause of Lung Cancer, While Moderate Smoking As Causation of Lung Cancer Has No Scientific Support]
- CTRMN005610E-5613 British Scientist Opposes Campaign Against Smoking Tobacco and Health Volume 1 Number 1 [Sir Ronald Fisher, British Statistician, Refuses to Produce Anti-Smoking Writing, States It As A Cause for Anxiety]
- CTRMN005610F-5613 'pick Your Expert, Take Your Choice' Tobacco and Health Volume 1 Number 1 [Witnesses Linking Cigarettes to Lung Cancer Testify Before House Operations Sub-Committee]
- CTRMN005610G-5613 'still Open Question' Tobacco and Health Volume 1 Number 1 [Authorities on Cancer State That Smoking Is Not Proven to Cause Lung Cancer]
- CTRMN005610H-5613 Smoking and Death Rates Tobacco and Health Volume 1 Number 1 [If Everyone Stopped Smoking There Would Be No Significant Change in Death Rate]
- CTRMN005614-5616 Summary of Comments for Delivery Before: Central Subsection, North Jersey Section, American Chemical Society, Elizabeth, New Jersey [Review of the Chemical Analysis of Cigarette Smoke and Investigations of Smoking and Lung Cancer]
- CTRMN005617-5620 the Public and Smoking Fear or Calm Deliberation? [How Doubt, Suspicion and Fear May Affect the Deliberation of Whether Cigarette Smoking Causes Lung Cancer or Other Ailments]
- CTRMN005621A-5624 TIRC Reports Progress in Smoking-Health Research Tobacco and Health Volume 1 Number 2 [Too Many Unknowns Exist Concerning Lung Cancer to Warrant Conclusions Citing Smoking As Causation of Lung Cancer]
- CTRMN005621B-5624 'tar' Misnomer for Condensed Smoke Tobacco and Health Volume 1 Number 2 [Difficulties in Analyzing Tobacco Smoke Make Tobacco Tar A Misnomer]
- CTRMN005621C-5624 New Statistics Contradict Anticigarette Theory Tobacco and Health Volume 1 Number 2 [Cigarette Smoking May Be Compatible with Normal Health Report on Done Smokers Who Have Longer That Average Life Span]
- CTRMN005621D-5624 TIRC Funds for Smoking Research Now Over $2,000,000 Tobacco and Health Volume 1 Number 2 [Scientific Advisory Board Approves 52 Grants and Renewals in 1957 Totalling $550,000]
- CTRMN005621E-5624 Press Questions Anti-Smoking Plan Tobacco and Health Volume 1 Number 2 [State-Supported Campaign Against Cigarettes Warranted in New York]
- CTRMN005621F-5624 Study Suggests Bronchitis May Be Prime Factor in Lung Cancer Tobacco and Health Volume 1 Number 2 [Preliminary Study at Beatty Institute Favors Bronchitis As A Factor of Lung Cancer]
- CTRMN005621G-5624 Doctors' Comments on Smoking-Health Tobacco and Health Volume 1 Number 2 [Increasing Number of New Chemicals in the Atmosphere at Fault for Rise in Cancer]
- CTRMN005621H-5624 Nation-Wide Lung Tissue Study Now Being Evaluated Tobacco and Health Volume 1 Number 2 [TIRC Studying Lung Tissues From 1,600 Persons]
- CTRMN005625-5648 Biological Aspects of Cancer Research Journal of the National Cancer Institute Vol. 30, No. 3 [St Background Research and New Information on Cancer Studies]
- CTRMN005649-5654 Interview the Cigaret Smoker and Lung Cancer Reprinted From Modern Medicine, Vol 26 [St Advises on Smoking and Its Relation to Health]
- CTRMN005655-5660 Comments on the Mortality of Smokers and Non-Smokers. A Paper by Harold W. Dorn Before the American Statistical Association Dec. 27, 1958 [Reflections on Figures Presented in Dorn's Paper]
- CTRMN005661-5671 An Experimentalist Looks at Statistics on Smoking [Reflections on the Figures in Dorn's Paper]
- CTRMN005672-5672 Letters to the Times Findings on Smoking [Statistical Proof of Link Between Smoking and Cancer Denied]
- CTRMN005673-5683 A Brief Review of the Smoking-Lung Cancer Theory [Review of Data Known on the Relation Between Cigarette Smoking and Lung Cancer]
- CTRMN005684-5686 Cancer-the Research Approach [Discussion on Cancer and A Category of Factors Which May Play Roles in Cause and Development of Cancer]
- CTRMN005687-5692 [Address Before the Burley and Dark Leaf Tobacco Export Association, Inc. Information About the Research Program Supported by the TIRC]
- CTRMN005693-5697 Some Phases of the Problem of Smoking and Lung Cancer the New England Journal of Medicine Vol. 264 No. 24 [St Disputes Findings That Smoking Causes Lung Cancer]
- CTRMN005698-5704 Some Aspects of the Lung Cancer Problem Reprinted From Punjab Medical Journal Vol. Xi No. 7 [St Discussion of Relationship of Cigarette Smoking to Lung Cancer]
- CTRMN005705-5735 Current Knowledge of Tobacco and Health [Discussion of Experimental Attack on Lung Cancer and Tobacco Use]
- CTRMN005736-5739 Cigarettes-Why More Research? Reprinted From the Yale Scientific Magazine [St Comments on the Uncertainties of the Correlations Between Cigarette Smoking and Lung Cancer]
- CTRMN005740-5740 Why Do People Think That Quitting Smoking Affects Their Appetite or Their Weight? the Apothecary [St Comments on the Scientific Basis of How Smoking Affects Hunger]
- CTRMN005741-5754 Address to Be Delivered by Dr. Clarence Cook Little, Scientific Director, the Council for Tobacco Research - U.S.A. At A Dinner Honoring the Centennial of the University of Kentucky and the Burley Tobacco Industry Lexington, Kentucky January 12, 1965 [Talk Addressing Research Programs of the University of Kentucky]
- CTRMN005755-5772 Communications and the Biological Sciences [Brief Discussion of Principles That Should Inspire and Guide Communications in the Biological Sciences]
- CTRMN005773-5785 Perspectives in the Experimental Approach to the Human Lung Cancer Problem [Experimental Research on Lung Tumors in Animals May Lead to Insights on Human Lung Cancer]
- CTRMN005786-5798 Tobacco and Health Research [Elaboration on the Purpose, Research Practices and Studies of the TIRC]
- CTRMN005799-5805 Tobacco and Health Research [Discussion of Experimental Studies by the TIRC Concerning Smoking and Health]
- CTRMN005806-5813 the Research Perspective on Smoking and Health [Discussion on the Search for Causes of Diseases with Which Smoking Has Been Associated]
- CTRMN005814-5820 Tobacco and Health Research [Discussion of Studies on Cigarettes and the Diseases Statistically Associated with Smoking]
- CTRMN005821-5834 Tobacco and Health Research - Where Shall We Go From Here? [Suggestions for Continuing Studies and Research on Cigarette Smoking and Health]
- CTRMN005835-5852 A Look Ahead Smoking and Health - Where Do We Stand? [Talk on Chronic Diseases and Factors of Their Causation and Development in Relation to Cigarette Smoking]
- CTRMN005853-5854 Smoking-Disease Links Continue to Lack Scientific Proof [Discusses the Role of the Council for Tobacco Research]
- CTRMN005854-5854 Lawrence Promoted to Vp Post at Mmi [Jack Riddle Announces the New Vp of Micro-Magnetic Industries]
- CTRMN005854A-5854 Philip Morris Expands Promotional Allowances [Discusses Special Offers Made to Philip Morris Vendors]
- CTRMN005855-5882 Chapter 3 the Tobacco Health Issue: An Overview of Medical Research [St Questions Methodology of Experiments Where the Sole Objective Was the Attempt to Induce Tumors]
- CTRMN005883-5900 the Research Program (Cancer Segment) of the Council for Tobacco Research - U.S.A., Inc. Presentation Before the Tobacco Working Group [Describes the Concept, Plan, and Purpose of the Council for Tobacco Research]
- CTRMN005901-5902 Smoking Prevention Education Act Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Eighth Congress First Session on H.R. 1824 [Statement of Sheldon C. Sommers]
- CTRMN005903-5919 [Regarding Anti-Smoking Bill]
- CTRMN005920-5931 Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Eighth Congress First Session on H.R. 1824 March 9 and 17, 1983 Serial No. 98-8 Statement of Robert Casad Hockett Regarding H.R. 1824 [Disputes Findings Set Forth in H.R. 1824 Regarding Cancer, Cardiovascular Disease, Atherosclerosis and Emphysema]
- CTRMN005932-5932 Hearings Before the Committee on Labor and Human Resources United States Senate Ninety-Eighth Congress First Session on S. 772 May 5 and 12, 1983 [Concerning Smoking Prevention Health and Education Act of 1983]
- CTRMN005933-5940 Statement of Sheldon C. Sommers, M.D., Consultant in Pathology, Lenox Hill Hospital, New York, N.Y. [Comments on Smoking Prevention Health and Education Act]
- CTRMN005941-5963 Hearings Before the Committee on Labor and Human Resources United States Senate Ninety-Eighth Congress First Session on S. 772 to Promote Public Health by Improving Public Awareness of the Health Consequences of Smoking and to Increase the Effectiveness of Federal Health Officials in Investigating and Communicating to the Public Necessary Health Information, and for Other Purposes Statement of Robert Casad Hockett Regarding S. 772 [Disputes Methodology of Experiments Which Expose Animals to Smoke]
- CTRMN005964-6009 Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Seventh Congress Second Session on H.R. 5653 and H.R. 4957 March 5, 11, and 12, 1982 Serial No. 97-106 [Disputes Methodology of Experiments to Demonstrate That Cigarette Smoking Can Cause Lung Cancer in Animals]
- CTRMN006010-6012 Testimony of Dr. Robert C. Hockett During Hearing on Cigarette Smoking and Health Before the Subcommittee on Oversight and Investigations of the House Committee on Interstate and Foreign Commerce, October 5, 1978 [Responds to Question Regarding Research on Health and Smoking]
- CTRMN006013-6023 Statement of Robert C. Hockett, Ph.D. Before the Subcommittee on Oversight and Investigation of the Committee on Interstate and Foreign Commerce in Response to the Letter Dated September 27, 1978 From the Chairman of the Subcommittee to William U. Gardner, Ph.D., Scientific Director, the Council for Tobacco Research - U.S.A., Inc [Discusses the Purpose of the Council for Tobacco Research]
- CTRMN006024-6069 Hearings Before the Subcommittee on Health of the Committee on Labor and Public Welfare United States Senate Ninety-Fourth Congress Second Session on S. 2902 February 19, March 24, and May 27, 1976 [Disputes Scientific Basis of S. 2902]
- CTRMN006070-6125 Hearings Before the Consumer Subcommittee of the Committee on Commerce United State Senate Ninety-Second Congress Second Session on S. 1454 Serial No. 92-82 [Discussion of Cigarette-Smoking and Peptic Ulcers]
- CTRMN006126-6135 Report of the Scientific Director [St]
- CTRMN006136-6189 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 February 1, 5, and 10, 1972 [Discusses Edimeological Comparisons Between Smokers and Non-Smokers]
- CTRMN006190-6200 [Bibliography Listing Over 1,275 Articles and Books About Tobacco and Disease]
- CTRMN006201-6311 [Articles About Tobacco and Disease]
- CTRMN006312-6321 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statement of Dr. Sheldon C. Sommers]
- CTRMN006322-6348 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statement of Dr. Robert Casad Hockett]
- CTRMN006349-6359 Hearings Before the Consumer Committee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statements of Dr. Sheldon C. Sommers and Dr. Robert C. Hockett]
- CTRMN006360-6370 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [References Reporting on Tobacco and Nicotine]
- CTRMN006371-6412 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Ninety-First Congress First Session on H.R. 643 A Bill to Amend the Federal Cigarette Labeling and Advertising Act with Respect to the Labeling of Packages of Cigarettes and for Other Purposes (and Similar Bills) [Statement of Dr. Sheldon C. Sommers]
- CTRMN006413-6492 Hearings Before the Committee on Commerce United States Senate Eighty-Ninth Congress First Session on S. 559 and S. 547 Bills to Regulate Labeling of Cigarettes and for Other Purposes [Statement of Dr. Clarence C. Little]
- CTRMN006493-6533 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug, and Cosmetic Act So to Make That Act Applicable to Smoking Products [Statement of the Council for Tobacco Research U.S.A. History and Organization]
- CTRMN006534-6540 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug and Cosmetic Act So As to Make That Act Applicable to Smoking Products [Statement of Clarence Cook Little, SC.D.]
- CTRMN006541-6548 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug, and Cosmetic Act So As to Make That Act Applicable to Smoking Products [Statement of Robert Casad Hockett, Ph.D.]
- CTRMN006549-6577 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Statement of Dr. Clarence Cook Little]
- CTRMN006578-6611 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Statement Concerning the Origin and Purpose of the Tobacco Industry Research Committee and Its Proposed Functions]
- CTRMN006612-6614 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Hartnett Cites Scientists Doubting Smoking-Cancer Theory]
- CTRMN006615-6618 Research Into Smoking and Health [Arguments Against Tobacco Cancer Link]
- CTRMN006619-6623 [Study to Examine Reported Causes of Death in Each of 17 Regions in Houston Specifically the Five Major Respiratory Diseases]
- CTRMN006624-6624 A Frank Statement to Cigarette Smokers [Industry Promotes Research Into Tobacco Disease Link]
- CTRMN006625-6625 the Council for Tobacco Research - U.S.A., Inc. Board of Directors [Members of the Board]
- CTRMN006626-6627 the Council for Tobacco Research - U.S.A., Inc. Scientific Advisory Board [Members of the Board]
- CTRMN006628-6634 No. E-121,486 I. D. Rogers, Individually and As Independent Executor of the Estate of Marjorie Helen Rogers, Deceased; Et Al Vs. R. J. Reynolds Tobacco Company, Et Al in the District Court of Jefferson County, Texas 172nd Judicial District Third Amended Notice of Intention to Take Oral Deposition [Matters on Which Ctr Witnesses Must Be Knowledgeable]
- CTRMN006635-6967 Deposition of Dr. James Glenn [Deposition of Glenn in the Matter of Broin]
- Author
- Little, C.C.
- Request
- 118
- Type
- ANNUAL REPORT
- Box
- 002
- UCSF Legacy ID
- xmq30a00
Document Images
ANNUAL ItI:POItT
u/ llic
SCIL'N"1'IFIC I)IIiF:C'I'OIi
CLAI(ENV:F: l:OO): LITI'LF:, tic.D.

TABLE OF CONTBV'I5 ~
I ~
Page
I .~
Ob.crvations . . . . . . . . . . . . . . . . . .
Research Findings . . . . . . . . . . . . . . . . 5
16
IV
:~
Z:
Abstracts o( Reports ~
U ~'..'
Grcinogenula Studies . . . . . . . . . . 29
. . . ~
Cardiovascular Studla . . . . . . . . . . . . . 32
Studics at the CcUular Levrl . . . . . . . . . . . . 43
Pulmonary Phyaiology and Anatomy Studies ...... 45
Psycho-Physiological Studies . . . . . . . . . . . 48
Tobacco Chemistry and Bjochcmiatry Studies ...... 49
Pharmacology Studies . . . . . . . . . . . . . 51
Other Studies . . . . . . . . . . . . . . . . 52
Recipients of Grants . . . . . . . . . . . . . . . . SS
i`

SCIIIY'I7F1C ADVISORY BOARD
to TLe Coancv iot Tobacco Raearcb--U.S.A.
KFNNEIH MPRRILL LYNCH, M.D., ScD., LL.D., Chairman
C/wnocllor and ProJuaor of Parholosy
Medical Colkya of Sootb Carolina, Charlcstoo, South Carolina
HOWARD B. ANDERVONT, Sc.D.
Scienr!/ic Editor, Tbe Journal of the National Cancer Institute
Bethesda, Maryland
RICHARD l. BiNd, M.D.
Pro/essor and Chobman, Departmatt of Medicine
Wayne Sute University College of Medicine, Detroit, Michigan
McKEEN CATTBLL, Px.D., M.D.
ProJcsror Enttritur of Phannacolopy
Cornell University MedicaJ Colkge, New York, N. Y.
LEON O. JACOBSON, M.D.
ProJessor and Chdrrrman, Department of Medicine
University of Cbiago
Dlnctor, Argonne Canocr Research Hospital, Chicago, Illinois
PAUL KOTIN, M.D.
.4srodate DJmtor for Field Studies
National Canoa IaKitute, Bethesda, Maryland
CLARENCE COOK LiTPLB, Sc.D., LL.D., Ltrr.D.
Scknd(.c DJ.eetar. The Council for Tobacco Research-U.S.A.
DLrcror F.mnitta, Raooa B. Jacbon Memorial Labocatory
Bar Harbot, Maino
STANLEY P. REIMANN, M.D., Sc.D.
Director Emsr/nu, The Insihttte for Canecr Research
PhBadelpaia, Pennsylvania
WILLiAM F. RIENHOFF, Ja., M.D.
Pro/esaor Enuritrr,r of Srorcry
Johns Hopkins UnIversity School of Medicine, Baltimore, Maryland
EDWIN B. WILSON. PN.D., LLD.
P!'Ofp7or E/Mrft4l of Vital SlGtlSticJ
Harvard University, Cambridge, Massachusetts
ROBERT C. HOCKETT, Ptr.D. J. MORRISON BRADY, M.D.
Axnoclote Scientific Director Associate Scientific Director
I
I
Observations
A decade has passed since the Tobacco Industry Research Committee,
now called The Council for Tobacco Research-U.S.A., and the Sckntitlc
Advisory Board began their work. During these ten years a major research
program on the relationships of smoking to health has been initiated,
amplified, and has gradually assumed clear-cut shape and direction.
Research on these and related problems haa similarly expanded under
many other auspices-Fedcral health agencitx, voluntary health and sci-
entific organizations, universities and medical schools, and teaching and
research hospitals.
Significant advances have occurred in scientific knowledge and under-
standing. It now seems appropriate to review the progress and the problems
of this first decade, and to consider their implications for the future.
Perhaps the most significant aspect of such a review is the realization
that the passage of a substantial period of titne-and the aocomplishmcnt
of a substantial bodyy of work-have not changed the fundamental prob-
lcros. As is often the case in basic scientific exploration, intensive research
has raised more new questions than it has answered; the task before us is,
i( anything, larger and more complex than it appeared a decade ago, and
the major research problems underlying the relationships of smoking to
health, though somewhat better dcfined, remain formidabk.
At the time the Board was established, for example, when cpi-
demiological studies reporting an association between cigarette smoking
and cancer of the lung were being advanood as a major support for the
hypothesis that this relationship was pusal, the need for intensive research
in many arcas-bioassay, genetip, pathoiogy, bioclxmistry and others-
to explore this and alternative hypothacs, and to elucidate basic under-
lying biological mechanisms, was evident. In the fntervening decade experi-
mental work in the various areas has raised many new issues. The need
for further knowledge (without which any hypothesis will lack confirma-
tion) is still clearly evident.
After ten years, the fact remains that knowledge is insufficient either
to provide adequate proof of any hypothesis or to define the basic mechan-
ums of health and disease with which we are concerned. It is true now
as it was in 1954 that continued research in all areas where knowledge
is de6cient offcn the best hope for the future.
5

Whik the substantive areas of research, and specific research results
have varied widely during this decade, catain broad principlcs have
emerged which serve as a useful guide to further planning. Among these
may be listed the foAowing:
(1) TAe Uechawring Motatre oJ Dt.ee.e
C'.onceptions of disease vary enormously with changes in methods of
detecting and defining them. Every new techniquc-and there have been
many-for the detection, description, analysis, treatment or prevention of
a disease entity tends to alter, to some extent, perception of that entity. Thus
it is easy to forget (but important to remember) that the basic noture of that
entity-whatever it is-remains unchanged.
The nature of the intracellular biochemical process that initiates the
development of a squamous cell carcinoma of the lung, for example, was
the same in 1664, 1764, 1864. and 1964, despite all the changes in knowl-
edge and view of it that have occurred during that time span. This under-
lying consistency of the basic process must be appreciated during the search
for facton which may initiate, accelerate or delay its occurrence. It is equally
important to be aware that any of these modifying factors could originate,
incrcase, diminish or disappear with the passage of time and with change
in bio->+ocial conditioos, and that these events could in turn lead to changes
in the relative frequency of different diseases.
The elucidation of such factors is important in direct proportion to
the extent that they throw light on the basic-and as yet imperfcctly
understood-mechanisms which they atfect.
(2) Tbe Distinction Between Direct Cawe, Contributing
Cwrae, .lagreratlon .nd 1Von-Speclfic Aa.ocJatlon
The importance of these distinctions in the search for basic knowledge
has also become evidrnt during the past decade. They must influence one's
thinking not only with regard to basic mcchanisms of disease but also
with regard to control, prevention and treatnxnt.
'llte problems raised by conditions which have been idcntificd as
"primary causes" of a disease entity (for example the tubercle bacillus
in tubcrculosis) are scientifically quite different from those raised by con-
ditions which have been identified as acting in certain instances, or by
conditions identified as non-specifically aasociated with a disease entity.
Further, the problems raised by agents which are selective in their
nature (e.g. sugar for diabetka) tuo vastly different from those which are
non-selective or omni-eIIective (e.g. botulinus toxin in food poisoning).
6
The latter are matters of universal eoncetn,.rhik the former focus atten-
tion on the need to define the mechanisms of selectivity and the nature of
the susceptible portion of the total population. Yet another type of problem
is raised by factors which through association may appear to be selective
but which are not eftcctive agents in the disease at all, for exampk, the
cating of corn and pcllagra.
Again, the distinction between agents which act "causally" and those
which aggravate or exacerbate the progress or development of a disease
once it is established is of obvious Importance both to an understanding
of mechanisms and to the design of effective intervention.
These distinctions underlie every consideration of morbidity, mortality
and prevention of disease.
These distinctions have not been adequately investigated in connec-
tion with lung cancer, cardiovascular or other diseases, by the types of
study which can yield pertinent data, and the design and conduct of such
study remains a major problem for the future.
(3) The Importance oJ llost Foctor. 1n Disease Re.ponse
Although the essential role of bost facton in disease response is rr:mg-
nized, very little organized research to detlne and analyze these lactors
has been or is being conducted in the area of smoking and health.
The fact that such research is difficult, costly and time-consuming haa
undoubtedly been a deterrent; one may recognize the practical inGuenoe
of this situation on the individual research worker who naturally prefers
to select problems towards the solution of which months rather than years,
and years rather than a life-time, will contn'bute.
Host factors promise particular pertinence In exploration of the problem
of lung cancer, which occurs in persons who have never been exposed to the
alleged causative agents, and which also occurs in only a very small pro-
portion of those who have been so exposed, sq that a major scientific
qucstion centers on the "why" and "how" of the detection and selection of
individuals who will develop lung cancer. The available evidence demands
attention to genetic, constitutional and other host factors.
Such knowledge is lacking. In the development of this knowledge one
must be realistic and patient. Tlte number of different genetic or constitu-
tional patterns among human individuals is vast, and the distinction
between most of them by any simple or convenient method is not as yet
practical. They arc unlikely to be of the genetically simple type which can
be detected by the methods of orthodox Mendelian analysis; they will, in
all probability, contribute to the discovery of biochemical types that can be
associated with relatively increased or decreased risks in a given individual.
7

a ,
'~'`11 '"~'
~t _
n/dle- V d0 a
ttM
~
1 ~ ^
bio~.ic~ l+etar>rW1,
a obWtt 'di+pt;` oI, dit
ptexw
oc Datwt.Doi.p
tatlo" ir tn.uatd~
apply 9111110101011
.
t>r. t...ltl.~ dtttar
,I1 rill 6 - r- rr0 the Imitations of
1~
POMWC
` ~
`by traiWOd pastonnol
ob.eiratio. (..~,
wbaa aoatrscy tted bat atabii.hod by the
trod txiostlec peooodtt~s;~ a.atysis to tako account
a ttu.y atrooottoaod .ai.ei~.. .
A p.rtic.i.r ptmbit+. In tttn eacre.t apoctrntn o( research on smokiag
and beakb Is tlre hck of Ittloe2 s, dkect loagtNdinal study of various
types of stnaDes popdatioot tttst:mbiod and controlled, measured, tcsted
and oaatvod for the origin and devoloprnent o( changes in physiobgical
prooea.es oi possibio slgnibqace as precursors to, or ateps In, the origin
and development o( chronic disease. Such studies require long-term eHort
by highly trained peraottncl and tLay are costly; yet the order of accuracy
of data from such eQotts Is likely to make them much more important than
turther repuition o( less exact typa of studia.
Fsstura Research
'Ibere are several ways in which the maln linu of future research
may be Listed and discuwod. But no matter in what way this is done it
should be rememberod that many overlapping and inta-related topics and
problems will eras tho boo.darip within any attempted classification.
At the pret+oot The G1QaracB fa Toa.cco Research is especially oon-
oerned with the Fnhlatiat nA4 t+tsppott of rrsearch under the following
broad
bqdinp.
A. Mot+a direct ob.arntttio~l cfldcat patboiogic studies of special
controlled poptl}atlcAL . I .
B. Ddlnitioa and e.abatiottt d motbods oi bioassay for whole smoke
and its prodnaM, fp~ttdie~ ebtmical analysis of smoke.
i
f
t
, ea~MrdtJGClkn mikrsaakw
Luft conoot Is a ra[e
f r.ctloo dcvelops loag
dlseat{a Of even the
tbo LssWI . only a very
thoe+elaw is to disoorot
wycbo-otrtotiooal) the p.j
'
and aoeraook~as, sfiicoo
sR
dF:eCt, ob.artatloml cddolt
~
r
uah ova laos poriod. aI tlaa: ;
Thero ara many ways In wbklt rttw tiad suoes ptomirtn= stodbs: may
be t+ct up. For exampb,)! oortaln coMdbt1 populations In htrgs medical
ocntas could be nadW trequost dh.ct obaa.atloo and tests, cfocs to
significant factors In the origin of eoetstitutboal or chronic dbease such
as cancer, cardiovascolar disease or chronic rapitatory disease might well
emerge. A pilot study along these lines Is already in progress.
It may be necessary to focus the attention of any such particular
expanded clinical study on one or two objectives chosen from the following:
lung cancer, cardiovascular diseases, chronic respiratory diseases, psycho-
emotional types. Wberever possible, honever, data on ap of the major
problems should be gathered.
It should also be noted that the use of twins Involving a comparison
of identical and non-identkal pairs Is a valuable technique which has not
been used nearly to the optimum degree.
Various factors as to which data ars already available in epidemio-
logical studies should also be borae In mind and should be included
wherever the prospect of obtaining pertinent and ralid data seems good.
Among these may be listed history of previous hrng infections, inhalation
vs. non-inhalation, family history of motbidlty and roortality, occupational
haurds, etc.
B. D.ju.lrlow and 8odwetlow./ M.t" .j db.a.oy
Some years ago the distinjuisbad biocSomhR Dr. A. J. Haagcn-Smit
stated to the Scientific Advisory Board to the Tobacco Industry Research
9

i
Commitme that
tta derrratlva would
number a aocat
CbeO1lG1 fraClbGatlon
rnetbod or JnOthodf of
ai tbeae various
xno.Io* ot
h in fatx vocy avodt
p40ooo saooka and
-
~
.
.
' a- r,.n ~ , a...z . >r,.,A
?~r"
!
w:.~.
i ifJ
{ .
U a
.
-n
'~
af
i: afa~.tiYiiVo!
aasay or for eralnatfot.
As assay tochniqtta
tt?l the (oa
rettl jttstLlcadoO o(
to o( Ws
1 OfIOCts
a[~t.
p[opnrrtha of smoke
for bWoSical
oo living anitm+la.
qtt dwi.ed., Including aaays
for measuring possibio "pnsFooVOkitya' bY ovett aomi-quantitativo methods,
our =enoral plan haa been /bsr to measuro over-all effects of whole smoke and
then, when a possibly significant biological effect has been detected, to trace
it to the specific substances or properties that may be responsible for it.
The spot-light of emphasis bas tberefore been consistently on biology
ratber than on chemistry.
In accord with this general plan, for example, The Council has con-
csntrated much morc attention upon the test and trial of systems for
evaluating the possible carcinosenitdty of whole smoke or of smoke con-
densates peepared under very carefully defined and reproducible condi-
tions, than upon the iwtation and idoatifleatioe of auch possible ingredients
as polynudear hydrocarbons. 9Vblie t+everal hydrocarbons of this class
have been ideatifiod in ~ttomoty amalA 3racss In cigarette smoke by in-
vestiptas under otbar apqoaorahip, tlat.0 fdiottbcatioos have not answered
the prime questiaa whttber sa>c1t naea' aue, aJoro the threshold of
biological aj=ni6eaooa up*x t!m tscrital eopdkions o( human life. Henoe
rnnoentratioa upon bio.wy tttiIl ootoorttdt ttpantion to a much greater
degree thw does chemical aasbytdr.
The Council for Tobacco ,R aeoaelt plans to focus major attention on
critique and itank evaluation a[ ttr pteseotfy used methods of bioasuy.
There would aocm b be c.etain tatiooa1 oonclusions that can be
drawn in the primary so3octb.>oi 'Ioottiotft and aasay. Three of these are
as fouows: '.
. ,
:. ..
h Wbar+c'ver po.sibllo, tbo oq.a or tlauo which shows pathogonic
changes fn man should bo.dw tarjot orytn or tissue in the animal
oaod.
II. Wherever posaibie, thu srai or a=eats suspoctcd of ctioloyical
patboyenic eap.city lp tiDo sito.id be appiiod to animals in the
same chemical 1p[s ' as 469 in ylid" k is applkd to man, e. j.,
wboi. aotoka
' 10
i
J
t
.
111. Whcrever poss(bb, too avspoctod a~eat or apents should bc
appLed to ~ li is applied to tahaa.
~ :
This does not ux>an ~ c~ o(,~y may not be taieltil
or valuable. It emP~. > es betweea admal
experiments and maa anralid apd scientific
conditions which aro attaiopb1p, prl.bipt seduced to a miaimum
and similarities be iacrnaod 'Op tt J§*ziMUta: 'i%p%b diQoneaoos amons
animal species tested wW always praruet tofr sjtnpia a.d diroet omapolatlon
to humans, data pined throuy4 tpdt 1eW pR'WY e.a aid understanding of
basic biochemical processes and twLpd Cliuictal abaratlona that abouid be
made directly on humans.
Whenever and wherever artiAcially isolatod or prepared fractions or
components of the naturally occurring form of a complex suspected agent
are used to prove the physiological activity of that agent certain principles
seem to apply:
First; it must be shown that a similar isolation or chemical process
to that which artificially produocs the derivative, takes place naturally in
human smoking. Results obtainod with a norttquivalent derivative arc
clearly not comparable to the actual problem In rlvo.
Second; it must be aAown that any effect of a prepared derivative or
component can be and is obtained by a less amount and by dosaas equIvaknt
to or less thap that which actually challenges the human dssue. Higher con-
centrations or larger do.cs of the challenging material create an entirely
different set of circumstanees biodbatkally speaking, and therefore art not
comparable with or quantitativetyttaasforttbie to the problem in humans.
Third; the method of apptkat{at or contad.rlth the challenged tissue
must be of the same nature as the .atural metbod of oontact 'or appl3ca-
tion in humans. The elfecta of possible m.chaaical or biochemical trauma
in a diffetent experimental procedure anust be toootnized as variables not
naturally occurring in man.
If an experimental targot organ or tissue different from that of man
is selected, the reasons for the ebok.ti must be stated and explained. Such
factors as greater ccxrvenLenco, economy and odrOr material advanta=es
must be frankly facod, evaluated and balanced agalrut the scientific varia-
bles and diBerences Involved. Factors of this sort have a strong pracNcnl
appeal. Premature or erroneous conclusions drawn from unsound premises
can, however, constitutc a=reat obstacle to the aeateb for the truth.
No matter, therefore, bow long and arduous may be the road t6 a
proper evaluation of methods of blousay and to the devdopment of a
sound perspective in their Intor-telatioasltips, that rwd must be traveled.
The Council intends to do its beat to aan that thia L ahe case.
11

G B'(1.arioJosy nwd Sfadatlosf .tnalyaJa
It is generally oonoeded sdenti8cally that epidemiological data on
mortality are not the basis for determining the origin of the diseases in which
tobacco has been asserted to play a role. Such data will be subject to continu-
ing study and evaluation by'Ihe Council for Tobacco Rcsearch and by other
agencies active in supporting laboratory or clinical research.
For example, atatiaticai findinp have suggested future research needs
aiong a number of lines.
I. Methods for deffaito quantitative meaaurement of the extent and
degree of inhalation need to be devised in order to facilitate the
detcrmination of the role, If any, which that process may play in
any estimated or observed physiobgical activity of imokc. The
present "quesiionnairo" or "personal opinion" method of csti-
mating the amourtt of inhalation is not as accurate as would be
others that aun bedriviriod. In such an Important iuue as the
quaatkatioa of the d.it.od .Geets o( wpoking, the most precise
aad impettonal stetbods of morawrnseat which are available are
essential to sound twientibc ov.loation. '
2 It would be impatant to determine any cumulative effects of ex-
powre to amoks and whether aocamulatlon It any proceeds at a
ateady aod matbomatically predictable rate. Studies are being, and
should oootinoe b be, tnade to gnd wbotber any "threshold" rola-
tiomhip oajsta.
3. A male excess In ioddeaae of and in mortality from most If not all
respiratory diseases Is particularly marked. On what is this de-
peadeat? To wbat dcgroo are endocrine factors involved in the
geaeaia or dcrdopm.at d tbeae diseases?
4. 73ero is ample evidence ihat oonftujon exists on a widespread
and qu+n<itstt ve2y .}goidcant scale in mortality records because
of failure to distinguish primary canoor o/ the lung from secondary
or mctastatic cancer bt the lung. Additional confusion exists in that
lung cancer ia oot cloady distinguished from other pathological
lesions which can be confused with it. These situations must be
corrected before an accurate picture of causative or contributory
factors in primary ltft eanoor can be obtained.
S. Ahlrough the actual aurabor ut deaths from lung cancer ia itr
uea.ing becutr of powhtiot; growth and because of larger
numbers of petsooa if tla,.;>d#tt ago grpups, the rate of inaeaae
io the ags-oorroolod 400 0 tsh bp boon slowing down since 1930.
I
.
A
This declining rate of increase, viewed in the light of actual and pa
capita consumption of cigarettes duriag this period, raises a serious
question concerning the validity of the simple causation theory and
demonstrates the need lor continued study and observation.
Undoubtedly new groupinp of data, new types or techniques of
analysis and indeed new types of controlled populations will suggest and
develop other problems of interest and importanee for further investigation.
If the limitations of epidcmiological research as well as Its suggestive and
stimulating value are kcpt In mind, itKreased activity in such studies will
be an important contributor to incrase in knowledge.
I). Paycho-PAyaloJosto.J Stwl{.a
There have been considerabie numbers of studies in this Be3d, all of
which support the belief that absotas of diffe¢tnt types and degrees may
differ from each other and from tsoo+arokOCs In pryrcho-pbysiol4c.l
characteristics re&ctod In habits of livins.
Certain elements, inbaent in the aatme of problems of this sort, mike
their solution complex arsd dif5cntt, however. This fact, while a deterrent
to undertaking racarch il the area, does not oooKitute a valid rea.oa for
neglecting to roooZnac the impataaoe ol tho topic or to take the sicps
necessary to ita further ao.lysis.
A promising hypothesis is that types and degrees of smoking, as well as
the practice of smoking versus non-.moking, art rdkctiotts of cluracterbtic
reactions of the individual in his adjustrneat to his fde experience. Scientific
study based on this hypothesis might And different categories of biochemical,
neurobgical, psychobgical, endoctioe and emotional drives or needs which
the individual experiences and which be trics to satisfy or to control by one
or more uses of, or abstioeaa froati a numbes of things such as tobacco,
alcohol, eoffee, tranquilizers, eacre}to, nareotics and food. Such study might
also find that the heavy cigarette smok.er, the moderate smoker and the non-
smoker will prove to be different In their psycho-physiobgial characteristks,
as the parallel groups under the other categories of responsive behavior to
life experience may also be.
Personality analysis by quationnalrsa or by hy Intaviews have been
made and these have provided leads which aro suggestive and which may be
developed by more refirlod methods of ro.o.reb. But it is ttnllYdy that it will
be su8icieat to try to eomplole tIIN analysis e( problems of psycbo-phytiul logical nature by this
sort o[ opitaiotbaied evl8eoc+a,
In the process of dowtfaj, reooeftsi and .oil.cdog significant dilTer_
ences in ways that can be tttadoalqod and analyaod, tbero aro r - wIn guida
13

which may Ps+obw
focysod on tlto
inaatan dha
produood by or
~
this way one anig}tt m
and iastab7ky, `
'.NICift 1.
~
ordinato ita program of retroarch t.M tboae of other inttmtod agencies.
The rrsult can only be an ircrwo in taodical kaow3odge which may rY.olve
questions regarding tob.ocp ta.e as well as ~aat: tpo therapeutic and pre-
ventatjve nsources ol bnmW tqodio~ ~' T
trd which miSM wa'darolcp iNo-
adoleaceats.
AtSpstlon should be
." ..>sieh the
Popstst/1 ftrom those
oarfooa.ot:nt. In
do"" ol stabiUty
*¢pu.trol ttad hcft of oon-
ci pwt Importa~oo for aduhs or
It is interesting that most physical anthropological studies which
attempt to correlate morphology and psycho-emotional traits have been
made on adults. In the adult stage the detection and measurement of the
psycho-emotional category of traits is complicated by the involved, cumula-
tive ncsponse to all the complexities and changing elements of the socio-
economic environment that the individual encountered over the years. Such
research is useful and lntaating. It would be much more so, however, if a
foundation of critical studies of children and adolescents was built under it
by future research.
An attempt should be made too, to find and to study characteristics
which involve close correlation of mental or emotional behavior with
variation in some definable and measurable biochemical or physiological
pruccssas.
Cotsdusion
These are a few of the many scientific problems to be confronted as
the research continues on tobacco use and human health. The Tobacco
Industry Research Committee has been an observer and initiator of re-
nearch irr this tkld uwa the period of an entire decade. The experience
pined during this period should aid The Council for Tobacco Research-
U.S.A. as it carries on this lmportant work. Certainly the research prob-
Ians to be faced are difficuh. They arc the problems posed to medicine
by the very nature of constitutional and chronic diseases. The etiology of
these diseases must be aought out and identified among all the factors that
affect human health from the first to the final decade of the human life
span. However, the outlook for a solution to these medical problems is
more encouraging today than it was when the Tobacco Industry Research
Committee was founded ten years ago. New agencies have joined in the
scientific eftort to understand probkms of tobacco use and human health.
Recently the American Medical Association announced a multi-million dollar
research effort. The Federal aovernment is expanding its own support of
research in this aros. There Is every reason to believe that The Council for
Tobacco Research-U.S.A. will be able to cooperate and effectively co-
I
14 15

Research Findings
T'bo Tobacco Indwtcy RaoarCh Committoo was formally organized 10
yeara ago to create a pr+o8raru of reiearcb ido ttmdamoatal health problems.
The pwgram was a:poctod spoo6cak b deralop facts regarding the effocts ~
of tobacco ttsa
A panel Of i cientiw and phyXicia" agarood to am as a Scientific ~
AdviaotY Board to t1r C,otoon" , eatabl}sblq policy, dcSnini probioaob
at~ t~ tuti~. ~ ~..!~ct t~o+t F~~ ~~
-" '
award ot tacn..at
TLa Coat+m atitl~,lw1~~l~i p m7 bbont«y t.cfltdoa
of its own. It was daeaia+bitt at t'j omst 04 LM raearch o( the C.omml<ooe
would be 8ocompWhod throogh a pt+oyam af grants-}n-aid to Independent
researchers working ln their own hMitutjom. The Coatmittee'a policics and
activities have eontinued under Its recent redaigtutlon as The Council for
Tobacco Racarch-U.S.A.
After a decade ot' support of «scarch It seems appropriate to review
s+omo of the sc'tentific Sndings that have been made. Through the eod of
1963 the Scientifb Adv't.ory Board recommended almost 500 grants for
research studies and The Council has in turn made awards totaling
$6,078.000.
The actual output sean(<iug from The Council's program has taken the
form of scicntiSc papers and reports published by individual invatigators in
mcdical and scientiflc journals. To date such publications have reached a
total of rnora than 350 reports. It Is to these repotu "Ibe Council musi turn
in attempting to evaluate the accomplishmeats of its program.
Of cottrse, it ia impossible to list all of the echievctacnts of Tbe Council's
raeat+ch. However, this review will attempt to dte some signiBcant illustra-
tivts examples.
Biowsay for Tumorigenic Action
A major difficulty with attempting to deduoe a causal connection from
the statistical association between cigarette smoking and the incidence of
various types of cancer, especially carcinoma of the lung, is that there am
a number of other noo-rausal reasons for the existence of such an auocia-
tioa which can be postulated and must be excludcd before aay final judg-
mtxst can be reached.
Since the simp{cst explanatory hypotlxais originally advanccd was the
possibility that tobacco unoke might have activity as a direct contact ur-
dnoaen, a large number of studies have been sponsored in the etIort to
develop reliable snd quantitative methods for asseaing atxh possible activity
in comparison with that of other substaooes and mixtures that are common
in the environment and whose tnmoeigeeie action Is kaown.
1. A survey of mocDankal smoktsg de.ioos was made and ooodhioos do-
fiocd under which a relattvoty uniform cigarette smoke oondearsato
could be made reproducibly. The ootsditioos wan so sQodtfed as to tall
within the range uadot whicb wo4pal traoke Is pcoducod by hvtma
clgaretm smolcess ttaofar ati pa~lbis.' Iattbntba by previous wodtert+
to the Importanoo ot oo.~Ds>~qott o1~d~ioai t+p t1t. ciotnio.l oompo.itsoa
and biodogial ttdt.lty al ,pto~a ooedooNMe ,tay 1!ae .itLttod the
results of many other earbw iaw.apson. .
2. Painting of smoke condensates from eommencial dgart:tta and from
cigar tobaccos and pipe tobaccos smoked in cigarette form on the skins
of mice has shown that their relative activities am inconsistent with the
statistical association between cancer Incidence and the smoking of
cigarettes, pipes and cigars. Moreover, the high dosages of smoke con-
dcnsata roquired in these experiments, and the nearly life-long treat-
ment periods required for minimal tumor production, attest to the
weakness of the activity of all such preparatiotts and raise doubts as to
whether normal human smoking could ever produce a dosage such as
to elicit this type of action.
3. The painting or fooding of potent carcinogenic substances has been
shown to increase the tolerance of mice to transplanted tumon or
normal skin from other mouse atraitu, which tnnsplants would be
rejected in the absence of this prettc.atment. This responsc could be
related quantitatively to the dosage of carcinogenic substance and thus
used as a bioassay tool. Standard cigarette amokc condensates tested
by this method were inactive.
4. It had previously been shown that several carcinogenic substances }n-
jected intravenously into certain mice would produce htng adcnomas
in numbers that were a simple function of the dose of carcinogen given.
These results were coafirmcd in a study sponsored by The Council.
Then standard cigarette smoke condensates, tmd from alkaloids so
that they could be given intravenously in large doses, were administered
in the same manner to the ume atraln of mice. No Increase In the
number of lung adnamaa was observed.
5. A one-ccll animal, parmrtalwn cnudaation, has been sApwn to be
rapidly killed by exposure to ultraviolet light after overnlght contact
with many carcinogenic substances of tbe potynutkar hydrocarbon
family in extremely small concentrations. Council projects have to-
16 17

studied this metbod extensively to refine It and develop maximum
eontroi of variables. Prelimfaary measurements with tobacco smokc
condensata have shown no Itxhal action for normal smoke.
6. Several studies in which mice of various strains were subjected to in-
balatioo of cigarette smoko at frequent intervals during their whole life
span have failed to produce aucinoma of the lung. Some inflammatory
changes were fouad, rather erratically, among the treated mice, and
these were accompanied by various degrees of tissue change. Such
changes wets, however, reversible If exposure was discontinued at
any point, ard never proceeded to invasive carcinoma even if exposure
waa continued.
7. Virus infections of the lungs of such mice were found to produce much
more extensive histopathologial effects than simple smoke inhalation.
Virus infection followed by long-term cigarette smoke inhalation pro-
duced such eflccts more frequently and at higher kvels, but without
production otcancer.
8. Condensates of tobacco smoke introduced into the lungi of several
animal species in the form of solutions or suspensions so that dosages
were higher than by inhalation of normal smoke have also failed to
produce carcinoma of the lung.
9. It has long been known that feeding urethane to strain A mice by
mouth will produce pulmonary tumors. Addition of nicotine, smoke
coodensatea or tobacco smoke inhalation was found in a Council study
not to enhance this effect. A further study discovcred that the vitamin
niacin has a defeasive action against the urethane tumor production
eHecx and that more tumors arc produced in niacin-defieicnt animals.
However, even in niacin-0eficicnt animals the inhalation of tobacco
smoke did not increase the production of pulmonary tumors following
urethane foediag.
10. Sprajue-Dawky male rats, fed dicta containing 2-acctylaminoAuorcne
and also exposed to cigarette smoke inhalation or injected with a to-
baooo smoke ooodensate In peanut oil, experienced a delay in the devel-
opmeat of liver changea that are considered to be indicative of a pre-
canoer%xn state (gross liver damage and lowering of riboflavin content).
Another condeasate, prepared by the standardized method referred to
elsewhere, did not affect either the rate of cancer induction or the final
tumor incidence in rats fed either 2-acetylaminoAuorepc pr 3'-methyl-
4-dimethyl-amlao.
11. It has been shown that small doses of chemical careinogens, which
alooe would not produoo cancers, will do so when injected into male
Swiss mice along with small do.es of certain common viruses, which
i
i
also do not produce cancer alone. TTie investigator showed that a com- M
bination occurs between the virus and the chemical substance ind poa-
tulated that the virus was able to carry the chemical into the interior of
the cell. Immunization of the animals against the viruses prevented the
cancer production. Etiorts to show a similar binding between these
viruscs and cigarette smoke condensate were unsuccessful.
12. Study of the sebaccous gland suppression in mouse skin by potynodcar
hydrocarbons has sholvn that the usefulness of this phenomenon for=
bioassay purposes is limited by the occurrence of false positive and :'
false negative reactions and by its relative Iaseasitivity to small changes
~'
in concentration or activity of the substances tested. V
13. Cigarette smoke condensatea in solution were appiied to the cervix and
upper vaginal area of more than 200 DBA-1 mice. 'Ibirty one percent of
mice painted twice weekly developed tumors.'Itte solvent applied alone
at a similar dosagc was followed by tumors In 60% of the mice and
treatment with a dry cotton applicator by tumors in 42.8%.
14. Animal and human lung cells have been successfully maintained in
tiuue cultures by several Council gnntees as a basis for development
of other possible methods of bioassay. In tissue culture form,ihuman
cellular material can be used for testing. Satisfactory and interptntable
methods for using such human cell material as a bioassay system for
carcinogenicity have still to be developed.
15. A number of other possible bioasaay systems have been tried or an;
under study with various degrees of success or promise.
The overall impression gained from these many b'toassay studies is
that tobacco smoke is inactive or of extremely minute activity In these several
artificial systems, none of which of course actually measures human rtsponae
under realistic conditions. The results lend little to support the hypothesis
that cigarette smoke can act as a direct contact carcinogen in the human
lung. Study is continuing with respect to other hypothetically possible modes
of action.
Ciliary.lctivity and Mucus Flow
A Council study undertook to evaluate the relative importance of the
activity of the cilia in the total machinery of lung clearance In intact animals
since it had been reported that cigarette smoke, like many other gases and
acrosols, diminished the activity of these hair-Uke appendages which coat
the upper respiratory tract and which normally propel upward the blanket
of mucus which carries inhaled dust and debris out of the lung and it had
been suggested that delayed elimination of inhaled dust and debris, contain-
18 19
